Results of the external quality assessment of Mycobacterium tuberculosis drug susceptibility testing in Russia, 2005-2007

International Journal of Tuberculosis and Lung Disease

Volumn 13, Issue 10, 2009, Pages 1294-1300

  Shulgina, Marina V ^a   Malakhov, V N ^a   Hoffner, S E ^b   Haile, M ^b   Wright, A ^c  

^a National Centre for External Quality Assessment in Laboratory Medicine   (Russian Federation)

^b SWEDISH INSTITUTE FOR INFECTIOUS DISEASE CONTROL   (Sweden)

^c WORLD HEALTH ORGANIZATION   (Switzerland)

Author keywords

Drug susceptibility testing; External quality assessment; Mycobacterium tuberculosis; Proficiency testing

Indexed keywords

ETHAMBUTOL; ISONIAZID; RIFAMPICIN; STREPTOMYCIN;

ARTICLE; DIAGNOSTIC ACCURACY; DRUG SAFETY; DRUG SENSITIVITY; EXTERNAL QUALITY ASSESSMENT; HUMAN; LABORATORY DIAGNOSIS; LUNG TUBERCULOSIS; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; QUALITY CONTROL; RUSSIAN FEDERATION; SWEDEN; TUBERCULOSIS;

ANTITUBERCULAR AGENTS; DRUG RESISTANCE, BACTERIAL; HUMANS; ISONIAZID; LABORATORIES; MICROBIAL SENSITIVITY TESTS; MYCOBACTERIUM TUBERCULOSIS; QUALITY ASSURANCE, HEALTH CARE; RIFAMPIN; RUSSIA; WORLD HEALTH ORGANIZATION;

EID: 70350113455     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Ministry of Health and Social Development of the Russian Federation. Tuberculosis in the Russian Federation, 2006: an analytical review of the main tuberculosis statistical indicators used in the Russian Federation. RF/FPHI/RIPP/CTRI/FSIN/WHO:126. Moscow, Russia: Ministry of Health and Social Development, 2007.
2. World Health Organization. Anti-tuberculosis drug resistance in the world. Report no. 4. WHO/HTM/TB/2008.394. Geneva, Switzerland: WHO, 2008.
3. Ruddy M, Balabanova Y, Graham C, et al. Rates of drug resistance and risk factor analysis in civilian and prison patients with tuberculosis in Samara Region, Russia. Thorax 2005; 60: 130-135.
4. World Health Organization. Global tuberculosis control: surveillance, planning, financing. WHO report 2008. WHO/HTM/TB/2008.393. Geneva, Switzerland: WHO, 2008.
5. World Health Organization. Laboratory biosafety manual. 3rd ed. WHO/CDS/CSR/LYO/2004.11. Geneva, Switzerland: WHO, 2004.
6. Canetti G, Froman S, Grosset J, et al. Mycobacteria: laboratory methods for testing drug sensitivity and resistance. Bull World Health Organ 1963; 29: 565-578.
7. Canetti G, Fox W, Khomenko A, et al. Advances in techniques of testing mycobacterial drug sensitivity, and the use of sensitivity tests in tuberculosis control programmes. Bull World Health Organ 1969; 41: 21-43.
8. Russian Federation Ministry of Health. Prikaz 109: [Instructions for unified methods of microbiological tests for tuberculosis case finding, diagnosis and treatment follow-up]. Amendment #11, Order #109. Moscow, Russia: MoH, 2003. [Russian]
9. Siddiqi K, Rüsch-Gerdes S. MGIT procedure manual. Geneva, Switzerland: Foundation for Innovative New Diagnostics, 2006.
10. Laszlo A, Rahman M, Espinal M, Raviglione M; World Health Organization/International Union Against Tuberculosis and Lung Disease Network of Supranational Reference Laboratories. Quality assurance programme for drug susceptibility testing of Mycobacterium tuberculosis in the WHO/IUATLD Supranational Reference Laboratory Network: five rounds of proficiency testing, 1994-1998. Int J Tuberc Lung Dis 2002; 6: 748-756.